Lifearc Is A British Life Science Medical Research Charity Dedicated To Translational Sciencewhich Connects Scientific Research With The Development Of Life Changing Treatmentsestablished In 2000 As Mrc Technologyit Rebranded To Lifearc And Gained Financial Independence Through The Sale Of Royalties From The Cancer Drug Pembrolizumabkeytruda This Financial Strength Enables Lifearc To Fund Various Initiatives And Projects In The Medical Field The Organization Offers Scientific Support And Advice To Researchershelping Them Navigate Challenges In Developing New Medicines And Diagnosticslifearc Also Provides Funding For Promising Researchparticularly In Rare Diseases And Global Health Issuesadditionallyit Facilitates Technology Transfermaking Scientific Discoveries More Appealing To Pharmaceutical Companieslifearc Collaborates With Various Partnersincluding The Uk Dementia Research Institute And The Fleming Initiativeto Advance Medical Science And Address Critical Health Challenges
